Our study was carried out to clarify the involvement of SMAD4 in the development and progression of colorectal carcinoma where it is reported to be mutated or deleted in about 20% of invasive cases [26] and the relationship between the mutant status of SMAD4 and KRAS genes. This evidence concerns the gene SMAD4 and colorectal carcinoma.